About Alpex Pharma
Alpex Pharma is a company based in Mezzovico-vira (Switzerland) founded in 2000. Alpex Pharma has raised $9.05 million across 1 funding round from investors including BB Biotech Ventures and Signet Healthcare Partners. Alpex Pharma offers products and services including Pharmaceutical Products, Nutraceuticals, and Formulation Development. Alpex Pharma operates in a competitive market with competitors including Kapiva, Jubilant Life Sciences, Recipharm, ChromaDex and Akums, among others.
- Headquarter Mezzovico-vira, Switzerland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alpex Pharma Sa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.05 M (USD)
in 1 rounds
-
Latest Funding Round
$9.05 M (USD), Series B
Aug 22, 2007
-
Investors
BB Biotech Ventures
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alpex Pharma
Alpex Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Products, Nutraceuticals, and Formulation Development.
Innovative drugs for therapeutic areas like pain management.
Nutritional products supporting wellness and disease prevention.
Services for developing and scaling pharmaceutical formulations.
Funding Insights of Alpex Pharma
Alpex Pharma has successfully raised a total of $9.05M through 1 strategic funding round. The most recent funding activity was a Series B round of $9.05 million completed in August 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $9.0M
-
First Round
First Round
(22 Aug 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2007 | Amount | Series B - Alpex Pharma | Valuation | BB Biotech Ventures |
Investors in Alpex Pharma
Alpex Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BB Biotech Ventures and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
PE firm investing in North America and Europe
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alpex Pharma
Financial Statements - Alpex Pharma
Alpex Pharma Comparisons
Competitors of Alpex Pharma
Alpex Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, Jubilant Life Sciences, Recipharm, ChromaDex and Akums, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ayurvedic healthcare and nutritional products are provided by Kapiva.
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
Nutritional ingredients for health and wellness are developed.
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
Frequently Asked Questions about Alpex Pharma
Alpex Pharma was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Alpex Pharma is headquartered in Mezzovico-vira, Switzerland. It is registered at Mezzovico-vira, Ticino, Switzerland.
Shahbaz Ardalan is the current CEO of Alpex Pharma.
Alpex Pharma is a funded company, having raised a total of $9.05M across 1 funding round to date. The company's 1st funding round was a Series B of $9.05M, raised on Aug 22, 2007.
Alpex Pharma was founded in 2000 and is based in Mezzovico Vira, Switzerland. Operations focus on the pharmaceutical sector as a contract research organization. Services encompass contract manufacturing, formulation development, nutritional supplements, prescription products, and drug delivery solutions. RD projects are also conducted for orodispersible tablet versions of existing drugs. Leadership is provided by CEO MD Shahbaz Ardalan.
Alpex Pharma's top competitors include Kapiva, Jubilant Life Sciences and Akums.
Alpex Pharma offers Pharmaceutical Products, Nutraceuticals, and Formulation Development.
Alpex Pharma has 2 investors. Key investors include BB Biotech Ventures, and Signet Healthcare Partners.